Quantitation of the inhibitory effect of fibrinogen and its degradation products on fibrin polymerization.
Anticlotting activities of fibrinogen and its plasmin degradation products--fragments X,Y and D--have been measured. On the molar basis fragments Y and D are found equally active whereas fragment X acts about 2 times stronger. We suggest that the inhibitory effect depends on a set of specific binding sites characteristic of domain D. As fragment X possesses two such sets its activity is twice as high as that of the single-set fragments Y and D. In spite of its two domains D fibrinogen inhibits clotting much weaker than fragment X. This is probably due to the presence in fibrinogen of large COOH-terminal sections of the two A infinity-chains interfering with the inhibitory effect. The possible role of these A infinity-chain sections in fibrinogen-fibrin system is discussed.